The Chambers Life Sciences Global Practice Guide provides the latest legal information on the regulatory framework for life sciences; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; their import, export and pricing; and regulatory reliance and fast-track registration.
Haykel Hajjaji, Julie Teperow, Robin Blaney, and Winsome Cheung authored the UAE Law and Practice chapter which provides an in-depth overview of the UAE’s life sciences regulatory framework at both the federal and emirate level, focusing on the recently overhauled UAE Pharmaceutical Law. The Chapter also outlines the requirements and issues around clinical trials, marketing authorizations, distribution and manufacturing, import and export, and pricing and reimbursement, for both pharmaceuticals and medical devices.
Winsome and Haykel authored the UAE Trends and Developments chapter which explores the key regulatory and market shifts shaping the UAE life sciences sector, highlighting the impact of legislative reform and greater regulatory alignment with international standards. The Chapter also examines evolving market dynamics, including increased investment activity, strategic transactions, and policy initiatives supporting local manufacturing and innovation.
Back
